Orphan drug for DMD

On 28 July 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 385. The active ingredient is 2-(4-(diethylamino) phenyl)-6-methyl-2H-benzo[d”>[1,2,3″> triazol-5-amine for treatment of DMD.